To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

The use of zolpidem for outpatient ACL reconstruction reduces narcotic consumption

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2014

The use of zolpidem for outpatient ACL reconstruction reduces narcotic consumption

Vol: 3| Issue: 1| Number:69| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial

Knee Surg Sports Traumatol Arthrosc. 2011 May;19(5):787-91. doi: 10.1007/s00167-010-1368-x. Epub 2011 Jan 21

Contributing Authors:
M Tompkins M Plante K Monchik B Fleming P Fadale

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

29 patients were randomized to assess the effect of a non-benzodiazepine hypnotic sleep-aid, Zolpidem, on postoperative narcotic requirements, pain, and fatigue in patients undergoing outpatient anterior cruciate ligament (ACL) reconstruction. Patients received either a single dose of Zolpidem or a gelatin capsule (placebo) for the first seven postoperative nights. Results indicated that Zolpidem ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue